Healthcare
| Company | Ticker | Margin |  Valuation |
|---|---|---|---|
| Medifast, Inc. | MED |
Undervalued by 56%
|
$59.25 |
| Abraxis Bioscience, Inc. | ABII |
Overvalued by 24%
|
$59.15 |
| ResMed Inc. | RMD |
Overvalued by 7%
|
$59.13 |
| China Biologic Products Inc | CBPO |
Overvalued by 52%
|
$59.05 |
| Edwards Lifesciences Corp | EW |
Overvalued by 51%
|
$58.94 |
| Fonar Corporation | FONR |
Undervalued by 181%
|
$58.83 |
| AstraZeneca plc (ADR) | AZN |
Undervalued by 71%
|
$57.93 |
| Omnicare, Inc. | OCR |
Overvalued by 40%
|
$57.86 |
| ICON plc (ADR) | ICLR |
Overvalued by 24%
|
$57.43 |
| NuVasive, Inc. | NUVA |
Overvalued by 14%
|
$57.04 |
| Kewaunee Scientific Corporation | KEQU |
Undervalued by 130%
|
$56.68 |
| Pharmacyclics, Inc. | PCYC |
Overvalued by 78%
|
$56.26 |
| Biostar Pharmaceuticals, Inc. | BSPM |
Undervalued by 1,378%
|
$56.19 |
| Teva Pharmaceutical Industries Ltd (ADR) | TEVA |
Undervalued by 10%
|
$55.61 |
| China Cord Blood Corp | CO |
Undervalued by 924%
|
$54.49 |
| Steris Corporation | STE |
Overvalued by 26%
|
$54.27 |
| PSS World Medical, Inc. | PSSI |
Undervalued by 86%
|
$54.02 |
| Paladin Labs Inc. | PLB |
Overvalued by 62%
|
$53.50 |
| Martek Biosciences Corp. | MATK |
Undervalued by 68%
|
$53.14 |
| Kensey Nash Corporation | KNSY |
Undervalued by 37%
|
$52.86 |
| Inverness Medical Innovations, Inc. | IMA |
Undervalued by 129%
|
$52.82 |
| Dynatronics Corporation | DYNT |
Undervalued by 1,992%
|
$52.72 |
| Mednax, Inc. | MD |
Overvalued by 21%
|
$50.85 |
| Techne Corporation | TECH |
Overvalued by 53%
|
$50.43 |
| Eli Lilly & Co. | LLY |
Overvalued by 38%
|
$50.36 |